menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Immunotherapy is starting to make its way in breast cancer, especially triple-negative breast cancer. So how do we identify which of our patients are good candidates for this treatment? Joining Dr. Pavani Chalasani to share the most recent research on immunotherapy is Dr. Nan Chen, an Assistant Professor of Medicine at the University of Chicago. 

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Immunotherapy is starting to make its way in breast cancer, especially triple-negative breast cancer. So how do we identify which of our patients are good candidates for this treatment? Joining Dr. Pavani Chalasani to share the most recent research on immunotherapy is Dr. Nan Chen, an Assistant Professor of Medicine at the University of Chicago. 

Facebook Comments

Schedule12 Aug 2022
Webpack App